Gene Therapy and Cell Therapy Through the Liver

Current Aspects and Future Prospects

  • Shuji Terai
  • Takeshi Suda

Table of contents

  1. Front Matter
    Pages i-x
  2. Mohammad Alsaggar, Dexi Liu
    Pages 1-11
  3. Cell Therapy

    1. Front Matter
      Pages 13-13
    2. Atsunori Tsuchiya, Stuart J. Forbes
      Pages 15-23
    3. Noriho Iida, Eishiro Mizukoshi, Shuichi Kaneko
      Pages 47-55
  4. Gene Therapy

    1. Front Matter
      Pages 57-57
    2. Hiroaki Mizukami, Jun Mimuro, Tsukasa Ohmori, Yoichi Sakata, Keiya Ozawa
      Pages 59-73
    3. Narumi Uno, Yasuhiro Kazuki, Mitsuo Oshimura
      Pages 75-83
    4. Kenya Kamimura, Takeshi Suda, Tsutomu Kanefuji, Takeshi Yokoo, Hiroyuki Abe, Yuji Kobayashi et al.
      Pages 85-92
  5. Legal Regulation

    1. Front Matter
      Pages 93-93
    2. Matthias Renner, Brigitte Anliker, Egbert Flory, Jürgen Scherer, Martina Schüßler-Lenz, Matthias Schweizer et al.
      Pages 105-123
    3. Susan Solomon, Mahendra S. Rao
      Pages 125-137
    4. Hanayuki Okura, Akifumi Matsuyama
      Pages 139-146
  6. Industrialization

About this book


This book reports the recent progress in gene and cell therapy through the liver and aims to facilitate a comprehensive understanding of the current aspects and future prospects from basic research to clinical therapies. Edited by pioneering researchers, this volume presents extensive information to principal investigators, researchers, postdocs, and clinicians for examining the wide varieties of pathological conditions both inside and outside the liver.

Providing not only the basic and clinical aspects of therapy, this volume is special in that it focuses on the administrative and regulatory difficulties of actual clinical application and legal regulations in different parts of the globe. By indicating the advantages and limitations of the most promising gene and cell therapies targeting the liver, this book will inspire readers to develop a feasible treatment in the next generation.


CPC Isolator adeno-associated virus (AAV) immunotherapy legal regulation liver fibrosis regeneration

Editors and affiliations

  • Shuji Terai
    • 1
  • Takeshi Suda
    • 2
  1. 1.Division of Gastroenterology and HepatologyGraduate School of Medical and Dental Sciences, Niigata University NiigataJapan
  2. 2.Department of Gastroenterology and HepatologyUonuma Institute of Community Medicine, Niigata UniversityNiigataJapan

Bibliographic information